MedTrace Logo

China Adrenal Disease Registry

NCT04890444 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-02-14

No results posted yet for this study

Summary

Epidemiologic studies have revealed a tremendous increase in the prevalence of adrenal associated disease and related mortality worldwide. In order to meet all the therapeutic challenges in adrenal disease in China, CASE was founded in 2020. The objective of CASE is to launch an adrenal disease management model based on the Internet health information platform which allows the application and evaluation of adrenal disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of adrenal disease, diagnosis, and treatment.

Conditions

  • Cushing Syndrome
  • Aldosteronism
  • Hypoadrenalism
  • Congenital Adrenal Hyperplasia
  • Adrenal Adenoma
  • Adrenal Incidentaloma
  • Adrenal Carcinoma
  • Pheochromocytoma

Sponsors & Collaborators

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04890444 on ClinicalTrials.gov